Efficacy Assessment of Three Non Pharmacological Therapies in Alzheimer's Disease

NCT ID: NCT00646269

Last Updated: 2013-08-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

640 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-03-31

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

ETNA3 is a multicentric randomised clinical trial conducted in France to evaluate the impact of cognitive training, reminiscence therapy and a "made-to-measure" program on the progression rate of dementia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

ETNA3 is a multicentric randomised clinical trial conducted in France to evaluate the impact of non pharmacological treatments on the progression rate of dementia: Three non pharmacological treatments are being studied: cognitive training therapy, reminiscence therapy and a "made-to-measure" program. Nearly 40 "Memory Clinics" are participating. 800 patients suffering Alzheimer's Disease in the mild to moderate stage of the disease will be included. For each therapy, a standard intervention protocol has been defined. The main objective is to determine whether any or several of these non pharmacological treatments can delay the severe stage of dementia during a 2-year follow-up. The secondary outcomes assess cognitive abilities, functional abilities in activities of daily living, behavioural disturbance, apathy, quality of life, depression, caregiver burden and resource utilization

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alzheimer's Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Group Type ACTIVE_COMPARATOR

Standard intervention protocol

Intervention Type BEHAVIORAL

The control group involves a standardized medical follow-up of patients with Alzheimer's disease and a psychoeducative group program for caregivers of patients.

2

Group Type EXPERIMENTAL

Standard intervention protocol + Cognitive training therapy

Intervention Type BEHAVIORAL

"Cognitive training therapy" is provided in small groups of 5 to 8 patients. It consists in classroom type sessions designed to provide general cognitive stimulation. A set of standard cognitive exercises (involving memory, attention, or problem-solving…) related to activities of daily living is realized at each session.

3

Group Type EXPERIMENTAL

Standard intervention protocol + Reminiscence therapy

Intervention Type BEHAVIORAL

"Reminiscence therapy" is provided in small groups of 5 to 8 patients. This therapy involves the discussion of past activities, events and experiences enhanced by aids such as photographs, familiar items, songs, or personal recordings. A particular topic of life (i.e. a wedding) is discussed at each session.

4

Group Type EXPERIMENTAL

Standard intervention protocol + "Made-to-measure" program

Intervention Type BEHAVIORAL

The "made to measure" program involves no systematic intervention. The psychologist is asked to choose among the two possible therapies ("Cognitive training therapy" or "Reminiscence therapy") the one more suitable for the patient after considering his clinical characteristics including socio-demographic characteristics, disease severity or cognitive and behavioural disturbance. It is an individualized approach emphasizing the importance of flexibility to allow adjustment to individual needs.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Standard intervention protocol

The control group involves a standardized medical follow-up of patients with Alzheimer's disease and a psychoeducative group program for caregivers of patients.

Intervention Type BEHAVIORAL

Standard intervention protocol + Cognitive training therapy

"Cognitive training therapy" is provided in small groups of 5 to 8 patients. It consists in classroom type sessions designed to provide general cognitive stimulation. A set of standard cognitive exercises (involving memory, attention, or problem-solving…) related to activities of daily living is realized at each session.

Intervention Type BEHAVIORAL

Standard intervention protocol + Reminiscence therapy

"Reminiscence therapy" is provided in small groups of 5 to 8 patients. This therapy involves the discussion of past activities, events and experiences enhanced by aids such as photographs, familiar items, songs, or personal recordings. A particular topic of life (i.e. a wedding) is discussed at each session.

Intervention Type BEHAVIORAL

Standard intervention protocol + "Made-to-measure" program

The "made to measure" program involves no systematic intervention. The psychologist is asked to choose among the two possible therapies ("Cognitive training therapy" or "Reminiscence therapy") the one more suitable for the patient after considering his clinical characteristics including socio-demographic characteristics, disease severity or cognitive and behavioural disturbance. It is an individualized approach emphasizing the importance of flexibility to allow adjustment to individual needs.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients in the mild to moderate stages of Alzheimer's Disease : MMSE score between 16 and 26 ; and stages 3 to 5 of the Global Deterioration Scale
* Patients over 50 years of age
* Patients with social security affiliation

Exclusion Criteria

* Patients suffering other type of dementia
* Institutionalized patients
* Patients with psychiatric disorder
* Patients with severe pathology in the terminal stages
* Patients receiving non pharmacological therapies other than that proposed in the study
* Enrollment in a pharmacological trial in the first 6 months
Minimum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Caisse Nationale de Solidarité pour l'Autonomie

OTHER

Sponsor Role collaborator

National Health Insurance Fund for Unemployed Workers

OTHER

Sponsor Role collaborator

Direction Générale de la Santé, France

OTHER

Sponsor Role collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

Sponsor Role collaborator

Université Victor Segalen Bordeaux 2

OTHER

Sponsor Role collaborator

University Hospital, Bordeaux

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jean-François, Dartigues, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Bordeaux

Geneviève Chêne, MD, PhD

Role: STUDY_CHAIR

University Hospital, Bordeaux

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CH Agen

Agen, , France

Site Status

CHU Amiens Nord

Amiens, , France

Site Status

Centre Mémoire de Ressources et de Recherches de Bordeaux, CHU de Bordeaux

Bordeaux, , France

Site Status

Hôpital Pellegrin

Bordeaux, , France

Site Status

CHU Côte de Nacre

Caen, , France

Site Status

Centre pour Personnes Agées

Colmar, , France

Site Status

Centre de Gériatrie

Dax, , France

Site Status

Hôpital Dupuytren

Draveil, , France

Site Status

Pôle de Gérontologie CHICAS

Gap, , France

Site Status

Les Fontaines de Monjous

Gradignan, , France

Site Status

CMRR & Neuropsychologie, Pavillon de Neurologie, CHU de Grenoble

Grenoble, , France

Site Status

Centre Hospitalier La Rochelle

La Rochelle, , France

Site Status

Association AA83 Alzheimer Aidants Var Etablissement " Les pensées "

La Seyne-sur-Mer, , France

Site Status

Centre Hospitalier de Libourne

Libourne, , France

Site Status

CHU Limoges

Limoges, , France

Site Status

Hôpital Privé Gériatrique Les Magnolias

Longjumeau, , France

Site Status

Centre Hospitalier Bretagne Sud

Lorient, , France

Site Status

Groupe Hospitalier Saint-Augustin

Malestroit, , France

Site Status

Hôpital Sainte-Marguerite

Marseille, , France

Site Status

Centre Antonin Balmes

Montpellier, , France

Site Status

Hôpital Gui de Chauliac

Montpellier, , France

Site Status

Clinique Neurologique, CHU Nord

Nantes, , France

Site Status

Centre Mémoire, Hôpital Pasteur,

Nice, , France

Site Status

Hôpital Broca

Paris, , France

Site Status

Hôpital de la Salpétrière,

Paris, , France

Site Status

Centre Hospitalier des Pyrénées

Pau, , France

Site Status

Hôpital de Jour Gériatrique

Pau, , France

Site Status

Hôpital Xavier-Arnozan

Pessac, , France

Site Status

CHI Poissy-saint-germain-en-laye

Poissy, , France

Site Status

Hôpital de Jour gériatrique

Poitiers, , France

Site Status

CHU de Rennes

Rennes, , France

Site Status

CHRU de Saint-Etienne

Saint-Etienne, , France

Site Status

Centre hospitalier Ariège Couserans

Saint-Girons, , France

Site Status

Hôpital de Jour Gériatrique

Saint-Raphaël, , France

Site Status

Hôpitaux universitaires de Strasbourg

Strasbourg, , France

Site Status

Bagatelle

Talence, , France

Site Status

CHIC Marmande - Tonneins

Tonneins, , France

Site Status

CHU Purpan-Casselardit

Toulouse, , France

Site Status

Hôpital des Charpennes

Villeurbanne, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Clare L, Woods RT, Moniz Cook ED, Orrell M, Spector A. Cognitive rehabilitation and cognitive training for early-stage Alzheimer's disease and vascular dementia. Cochrane Database Syst Rev. 2003;(4):CD003260. doi: 10.1002/14651858.CD003260.

Reference Type BACKGROUND
PMID: 14583963 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2007/17

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.